Psilocybin treatment extends cellular lifespan, improves survival of aged mice

9 months ago

Psilocin, a byproduct of psilocybin, extends cellular lifespan by over 50% in human skin and lung cells.
Aged mice treated with psilocybin showed a 30% increase in survival and improved physical health markers.
Psilocybin impacts aging by reducing oxidative stress, improving DNA repair, and preserving telomere length.
The study suggests psilocybin could influence systemic aging processes, especially when administered later in life.
U.S. life expectancy lags behind similar countries, highlighting the need for interventions that improve healthy aging.
Psilocybin may contribute to healthier aging, improving both lifespan and quality of life in later years.
Further research is needed to understand psilocybin’s systemic effects in aging populations and its potential clinical applications.

Hasty Briefsbeta